Superior vena cava syndrome secondary to hickman catheter in the advanced cervical cancer patient treated with concurrent chemoradiotherapy: A case report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Most of superior vena cava syndrome are caused by malignant tumors involving the mediastinum (usually lung cancer or lymphoma). However, iatrogenic cause has become more important since it has become common to utilize long-term central venous catheters for chemotherapy or hyperalimentation therapy. Although the cancer patients are also at relatively high risk, there are only few case reports of superior vena cava syndrome in gynecologic cancer. We present a case of iatrogenic superior vena cava syndrome related with Hickman catheter in advanced cervical cancer patient treated with concurrent chemoradiotherapy.
Abstract
Most of superior vena cava syndrome are caused by malignant tumors involving the mediastinum (usually lung cancer or lymphoma). However, iatrogenic cause has become more important since it has become common to utilize long-term central venous catheters for chemotherapy or hyperalimentation therapy. Although the cancer patients are also at relatively high risk, there are only few case reports of superior vena cava syndrome in gynecologic cancer. We present a case of iatrogenic superior vena cava syndrome related with Hickman catheter in advanced cervical cancer patient treated with concurrent chemoradiotherapy.
참고문헌 (15)
- Griffin D, "Superior vena cava syndrome during chemotherapy for stage 3c fallopian tube adenocarcinoma", Gynecol Oncol, 93, pp.257~259 (2004)
- Matthews JA, "Iatrogenic superior vena cava syndrome treated with streptokinase", Gynecol Oncol, 26, pp.119~122 (1987)
- Puleo JG, "Superior vena cava syndrome associated with gynecologic malignancy", Gynecol Oncol, 23, pp.59~64 (1986)
- Kitagawa R, "A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer", Gynecologic Oncology, 125, pp.307~311 (2012)
- 최일정, "The Efficacy of Concurrent Cisplatin and 5-Flurouracil Chemotherapy and Radiation Therapy for Locally Advanced Cancer of The Uterine Cervix", Journal of Gynecologic Oncology, 19(2), pp.129~134 (2008), 대한부인종양학회
- Schifferdecker B, "Nonmalignant superior vena cava syndrome: pathophysiology and management", Catheter Cardiovasc Interv, 65, pp.416~423 (2005)
- Bertrand M, "Iatrogenic superior vena cava syndrome. A new entity", Cancer, 54, pp.376~378 (1984)
- Estes JM, "Complications of indwelling venous access devices in patients with gynecologic malignancies", Gynecol Oncol, 91, pp.591~595 (2003)
- Markman M, "Diagnosis and management of superior vena cava syndrome", Cleve Clin J Med, 66, pp.59~61 (1999)
- Preston CI, "Intermittent superior vena cava syndrome caused by a Hickman catheter", Clin Oncol (R Coll Radiol), 4, pp.60~61 (1992)
- Roberts JR, "Multimodality treatment of malignant superior vena caval syndrome", Chest, 116, pp.835~837 (1999)
- Akl EA, "Anticoagulation for patients with cancer and central venous catheters", Cochrane Database Syst Rev, 4, pp.006468~ (2011)
- Young AM, "Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial", Lancet, 373, pp.567~574 (2009)
- Prandoni P, "Prophylaxis of catheter-related thrombosis in cancer patients", Lancet, 373, pp.523~524 (2009)
- Minassian VA, "Longterm central venous access in gynecologic cancer patients", J Am Coll Surg, 191, pp.403~409 (2000)